Skip to main content
. 2017 Mar 29;2017:8216878. doi: 10.1155/2017/8216878

Table 4.

Association of eGFR category and cardiovascular mortality.

Estimating equation category, mL/min/1.73 m2 Age adjusted incidence rate per 1,000 person years (95% CI) Hazard ratio (95% confidence interval)
Unadjusted (site only) Base model MV model Final model
BIS1
 ≥75 45.7 (0.8, 90.6) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
 60 to <75 16.5 (11.7, 21.3) 0.8 (0.5, 1.2) 0.7 (0.4, 1.1) 0.8 (0.5, 1.2) 0.8 (0.5, 1.2)
 45 to <60 18.7 (14.6, 22.8) 1.3 (0.8, 2.0) 0.9 (0.6, 1.3) 0.9 (0.6, 1.4) 0.9 (0.6, 1.3)
 <45 38.4 (22.9, 53.9) 3.4 (2.2, 5.5) 1.8 (1.1, 2.9) 1.6 (0.9, 2.6) 1.4 (0.9, 2.4)
p-trend <0.001 0.005 0.036 0.099
CKD-EPIcr
 ≥75 19.1 (14.7, 23.4) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
 60 to <75 19.1 (14.4, 23.8) 1.4 (1.1, 2.0) 1.1 (0.8, 1.6) 1.1 (0.8, 1.5) 1.0 (0.7, 1.4)
 45 to <60 20.3 (13.0, 27.6) 1.6 (1.1, 2.4) 1.2 (0.8, 1.7) 1.0 (0.7, 1.5) 1.0 (0.7, 1.5)
 <45 39.7 (21.9, 57.5) 4.1 (2.7, 6.1) 2.6 (1.7, 4.0) 2.1 (1.3, 3.2) 1.8 (1.2, 2.8)
p-trend <0.001 <0.001 0.016 0.043
BIS2
 ≥75 19.4 (9.6, 29.2) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
 60 to <75 16.4 (12.1, 20.8) 0.9 (0.5, 1.5) 0.8 (0.5, 1.4) 0.9 (0.5, 1.5) 0.8 (0.5, 1.4)
 45 to <60 19.8 (15.6, 23.9) 1.6 (0.9, 2.6) 1.1 (0.7, 1.8) 1.1 (0.7, 1.9) 1.1 (0.6, 1.8)
 <45 37.5 (25.5, 49.6) 3.7 (2.2, 6.3) 2.2 (1.3, 3.8) 1.9 (1.1, 3.4) 1.7 (0.9, 3.0)
p-trend <0.001 <0.001 0.001 0.006
CKD-EPIcr,cysc
 ≥75 17.5 (12.4, 22.6) 1.0 (reference) 1.0 (reference) 1.0 (reference) 1.0 (reference)
 60 to <75 17.8 (13.6, 21.9) 1.3 (0.9, 1.9) 1.1 (0.8, 1.6) 1.1 (0.8, 1.6) 1.1 (0.8, 1.6)
 45 to <60 21.5 (15.8, 27.3) 2.2 (1.5, 3.2) 1.5 (1.0, 2.2) 1.4 (0.9, 2.0) 1.3 (0.9, 1.9)
 <45 48.3 (21.4, 75.2) 3.9 (2.6, 5.9) 2.5 (1.7, 3.8) 2.0 (1.3, 3.1) 1.8 (1.2, 2.8)
p-trend <0.001 <0.001 0.002 0.011

eGFR, estimated glomerular filtration rate; BIS, Berlin Initiative Study; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; cr, creatinine; cysc, cystatin C.

Adjusted for age, race, and body mass index.

Adjusted for age, race, body mass index, hypertension, and diabetes mellitus.

Adjusted for age, race, body mass index, hypertension, diabetes mellitus, history of CHD, and self-reported health status.